{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:59:15Z","timestamp":1767182355776,"version":"build-2238731810"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T00:00:00Z","timestamp":1390780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085059","type":"journal-article","created":{"date-parts":[[2014,1,27]],"date-time":"2014-01-27T16:21:43Z","timestamp":1390839703000},"page":"e85059","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting the Biophysical Properties of the Myeloma Initiating Cell Niches: A Pharmaceutical Synergism Analysis Using Multi-Scale Agent-Based Modeling"],"prefix":"10.1371","volume":"9","author":[{"given":"Jing","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Song","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianguo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beini","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Che","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,1,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/modpathol.3880427","article-title":"A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry","volume":"14","author":"CC Chang","year":"2001","journal-title":"Mod Pathol"},{"key":"ref2","article-title":"Determining the phenotype of clonotypic B-lymphocytes in multiple myeloma by flow cytometry","author":"C-CC Joe Conway","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2003-09-3064","article-title":"Characterization of clonogenic multiple myeloma cells","volume":"103","author":"W Matsui","year":"2004","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1158\/0008-5472.CAN-07-3096","article-title":"Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance","volume":"68","author":"W Matsui","year":"2008","journal-title":"Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1084\/jem.20052136","article-title":"Enhancement of clonogenicity of human multiple myeloma by dendritic cells","volume":"203","author":"A Kukreja","year":"2006","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0301-472X(01)00788-3","article-title":"Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD\/SCID mice","volume":"30","author":"LM Pilarski","year":"2002","journal-title":"Exp Hematol"},{"key":"ref7","first-page":"301","article-title":"Unraveling the biology of multiple myeloma disease: cancer stem cells, acquired intracellular changes and interactions with the surrounding micro-environment","volume":"95","author":"J Caers","year":"2008","journal-title":"Bull Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1073\/pnas.0611682104","article-title":"Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma","volume":"104","author":"CD Peacock","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","article-title":"Cancer stem cells in multiple myeloma","author":"N Ghosh","year":"2008","journal-title":"Cancer Lett"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1200\/JCO.2007.15.8428","article-title":"Multiple myeloma cancer stem cells","volume":"26","author":"CA Huff","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","article-title":"Cancer stem cells: an old idea\u2013a paradigm shift","volume":"66","author":"MS Wicha","year":"2006","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"T Lapidot","year":"1994","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"M Dean","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3324\/haematol.2008.002766","article-title":"Changing paradigms in the treatment of multiple myeloma","volume":"94","author":"J Blade","year":"2009","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/14728210802676278","article-title":"Emerging therapies for multiple myeloma","volume":"14","author":"K Podar","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/leu.2008.396","article-title":"Role of autologous and allogeneic stem cell transplantation in myeloma","volume":"23","author":"WI Bensinger","year":"2009","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbiomolbio.2009.10.004","article-title":"Unique biomechanical interactions between myeloma cells and bone marrow stroma cells","volume":"103","author":"Y Feng","year":"2010","journal-title":"Prog Biophys Mol Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1089\/scd.2010.0010","article-title":"Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells","volume":"19","author":"Y Feng","year":"2010","journal-title":"Stem Cells Dev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.1171837","article-title":"The increasing complexity of the cancer stem cell paradigm","volume":"324","author":"JM Rosen","year":"2009","journal-title":"Science"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10555-008-9173-4","article-title":"Mechanics, malignancy, and metastasis: the force journey of a tumor cell","volume":"28","author":"S Kumar","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.leu.2402924","article-title":"Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms","volume":"17","author":"Y Nefedova","year":"2003","journal-title":"Leukemia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccr.2005.05.024","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"7","author":"JA Joyce","year":"2005","journal-title":"Cancer Cell"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A perivascular niche for brain tumor stem cells","volume":"11","author":"C Calabrese","year":"2007","journal-title":"Cancer Cell"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.exphem.2007.01.024","article-title":"Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions","volume":"35","author":"KC Anderson","year":"2007","journal-title":"Exp Hematol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7389","DOI":"10.1016\/j.biomaterials.2011.06.042","article-title":"Regulation of hepatic stem\/progenitor phenotype by microenvironment stiffness in hydrogel models of the human liver stem cell niche","volume":"32","author":"OA Lozoya","year":"2011","journal-title":"Biomaterials"},{"key":"ref26","unstructured":"Serban MA, Scott A, Prestwich GD (2001) Use of Hyaluronan-Derived Hydrogels for Three-Dimensional Cell Culture and Tumor Xenografts. Current Protocols in Cell Biology: John Wiley &amp; Sons, Inc."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","article-title":"CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy","volume":"113","author":"AK Azab","year":"2009","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2184.2006.00369.x","article-title":"Mathematical model for the cancer stem cell hypothesis","volume":"39","author":"R Ganguly","year":"2006","journal-title":"Cell Prolif"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.clpt.6100202","article-title":"Symmetric division of cancer stem cells\u2013a key mechanism in tumor growth that should be targeted in future therapeutic approaches","volume":"81","author":"BM Boman","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukaemia","volume":"435","author":"F Michor","year":"2005","journal-title":"Nature"},{"key":"ref31","article-title":"Cancer stem cell, niche and EGFR decide tumor development and treatment response: A bio-computational Simulation Study","author":"X Zhu","year":"2010","journal-title":"journal of theoretical biology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.biophys.31.101101.140930","article-title":"Computational cell biology: spatiotemporal simulation of cellular events","volume":"31","author":"BM Slepchenko","year":"2002","journal-title":"Annual review of biophysics and biomolecular structure"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/1471-2105-10-350","article-title":"Local cell metrics: a novel method for analysis of cell-cell interactions","volume":"10","author":"J Su","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nnano.2010.23","article-title":"Three-dimensional tissue culture based on magnetic cell levitation","volume":"5","author":"GR Souza","year":"2010","journal-title":"Nat Nanotechnol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14228","DOI":"10.1073\/pnas.0400067101","article-title":"A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells","volume":"101","author":"C Hirschmann-Jax","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.leukres.2009.05.024","article-title":"Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition","volume":"34","author":"J Wen","year":"2010","journal-title":"Leuk Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"CT Keith","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7994","DOI":"10.1158\/1078-0432.CCR-04-1087","article-title":"Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses","volume":"10","author":"L Zhao","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2141.2007.06895.x","article-title":"P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells","volume":"140","author":"J Wen","year":"2008","journal-title":"Br J Haematol"},{"key":"ref40","first-page":"313","article-title":"Effect of combinations: mathematical basis of problem","volume":"114","author":"S Loewe","year":"1926","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"RJ Tallarida","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Alon U (2006) An introduction to system biology: Disign principles of biological circuits. Boca Raton, FL: Taylor and Francis group.","DOI":"10.1201\/9781420011432"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jtbi.2004.06.031","article-title":"Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model","volume":"231","author":"JL Segovia-Juarez","year":"2004","journal-title":"J Theor Biol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jtbi.2004.04.016","article-title":"A mathematical model of the effects of hypoxia on the cell-cycle of normal and cancer cells","volume":"229","author":"T Alarcon","year":"2004","journal-title":"J Theor Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jtbi.2006.06.034","article-title":"Development of a three-dimensional multiscale agent-based tumor model: simulating gene-protein interaction profiles, cell phenotypes and multicellular patterns in brain cancer","volume":"244","author":"L Zhang","year":"2007","journal-title":"J Theor Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1182\/blood-2010-02-267344","article-title":"Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications","volume":"117","author":"J Jakubikova","year":"2011","journal-title":"Blood"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e56132","DOI":"10.1371\/journal.pone.0056132","article-title":"Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Treatment with Bortezomib","volume":"8","author":"TB Shabaneh","year":"2013","journal-title":"PLoS ONE"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e56954","DOI":"10.1371\/journal.pone.0056954","article-title":"Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells","volume":"8","author":"M Nara","year":"2013","journal-title":"PLoS ONE"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0112421","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,10,28]],"date-time":"2014-10-28T00:00:00Z","timestamp":1414454400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T22:43:26Z","timestamp":1688942606000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085059"}},"subtitle":[],"editor":[{"given":"Persio","family":"Dello Sbarba","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,27]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085059","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,27]]}}}